Replies to post #294346 on Amarin Corp Plc (AMRN)

[HDGabor]

J- (&Will Lar)

EU protection:

2021* - 2031**: 10*** years regulatory exclusivity
2031* - (IIRC) 2033/24: protection by patent(s)

* from date of the approval by EU Committee
** in case of new, approved indication: 2032
*** "breakdown" (IIRC): 8 yrs data protection (like in Canada) + 2 yrs market protection

Best,
G

[sts66]

You're correct - someone (alm2?) mentioned the other day that I was wrong about us having a max 10 yr protection from generics in the EU - that's how long exclusivity can run, meaning generics cannot challenge the R-IT patents until then - then they have to get the patents overturned. AMRN gets a minimum of 15 yrs of patent protection in the EU.